Intelligence · Clinical Pipeline
Vera Therapeutics Pipeline
All ClinicalTrials.gov programs at Vera Therapeutics — phase, modality, and trial IDs.
- Programs
- 4
Quick answer
Vera Therapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Atacicept
Vera Therapeutics
IgA Nephropathy
1 trial -
Atacicept
Vera Therapeutics
Lupus Nephritis (LN)
1 trial -
Immune Globulin 10% Intravenous Solution
Vera Therapeutics
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
1 trial -
Topotecan HEXAL 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Paclitaxel AqVida 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Paclitaxel Ribosepharm 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Anastrozol STADA® 1 mg Filmtabletten, Caelyx pegylated liposomal 2 mg/ml concentrate for solution for infusion, VS-6766, LETRO-cell® 2,5 mg Filmtabletten, VS-6063, Letrozol - 1 A Pharma® 2,5 mg Filmtabletten, ZOLSKETIL pegylated liposomal 2 mg/mL concentrate for dispersion for inf
Vera Therapeutics
Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
1 trial
Frequently asked questions
How many pipeline programs does Vera Therapeutics have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs